132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107
(215) 955-9077
(215) 955-5681 fax
1170 Main Building
Philadelphia, PA 19107
(215) 955-9077
(215) 955-5681 fax
Most Recent Peer-reviewed Publications
- Limited Sampling Estimates of Epigallocatechin Gallate Exposures in Cirrhotic and Noncirrhotic Patients With Hepatitis C After Single Oral Doses of Green Tea Extract
- Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome
- Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients
- Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis
- Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
Medical School
University of Pittsburgh - 1995
Residency
Thomas Jefferson University Hospital
Fellowship
Thomas Jefferson University Hospital
Board Certification
Internal Medicine
Clinical Pharmacology
Hospital Appointment
Thomas Jefferson University Hospital
Expertise and Research Interests
Research Interests:
Phase one clinical trials
Treatment of neonatal abstinence syndrome
Clinical Pharmacology
Clinical Interests:
Anticoagulation
Hospital-based vascular medicine consultation
Industrial Relevance
Dr. Kraft has expertise in the clinical, regulatory, and managerial aspects of Phase 1 drug development.